etoposide has been researched along with luteolin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CA; López-Lazaro, M; Willmore, E | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chowdhury, AR; Goswami, A; Majumder, HK; Mandal, S; Mukhopadhyay, S; Sharma, S | 1 |
| Ayuso, MJ; Cortés, F; Gálvez, M; López-Lázaro, M; Martín-Cordero, C | 1 |
| Das, A; Das, R; Majumder, HK; Mandal, C; Mukherjee, M; Mukherjee, T; Sengupta, T | 1 |
| Honkakoski, P; Hytti, M; Kaarniranta, K; Kauppinen, A; Korhonen, E; Petrovski, G; Piippo, N; Szabó, D | 1 |
| Berman, C; Emmanuel, F; Goodenow, D; Richardson, C; Sahyouni, M | 1 |
| Couture, R; Martin, LJ; Nguyen, HT; Touaibia, M | 1 |
9 other study(ies) available for etoposide and luteolin
| Article | Year |
|---|---|
Cells lacking DNA topoisomerase II beta are resistant to genistein.
Topics: Animals; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Genistein; Luteolin; Mice; Molecular Structure | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I.
Topics: Amsacrine; Animals; Antineoplastic Agents; Base Sequence; Betulinic Acid; Catalysis; Cell Nucleus; DNA, Superhelical; Enzyme Inhibitors; Etoposide; Flavonoids; Kinetics; Liver; Luteolin; Nucleic Acid Denaturation; Oligodeoxyribonucleotides; Pentacyclic Triterpenes; Plant Leaves; Quercetin; Rats; Spectrometry, Fluorescence; Topoisomerase I Inhibitors; Triterpenes | 2002 |
Cytotoxic effect of Plantago spp. on cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; DNA Damage; DNA, Superhelical; Etoposide; Flavonoids; Glucosides; Humans; Inhibitory Concentration 50; Luteolin; Plant Extracts; Plant Leaves; Plantago; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2003 |
Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amino Acid Sequence; Animals; Dimerization; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Hydrolysis; Leishmania donovani; Luteolin; Molecular Sequence Data; Mutation; Protein Conformation; Sequence Alignment; Sequence Homology, Amino Acid; Topoisomerase II Inhibitors; Triterpenes | 2005 |
Two dietary polyphenols, fisetin and luteolin, reduce inflammation but augment DNA damage-induced toxicity in human RPE cells.
Topics: Acetylation; Anti-Inflammatory Agents, Non-Steroidal; Cell Death; Cell Line; Cytokines; Dietary Supplements; DNA Damage; Etoposide; Flavonoids; Flavonols; Humans; Luteolin; Retinal Pigment Epithelium; Retinitis; Sirtuin 1; Tumor Suppressor Protein p53 | 2017 |
Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.
Topics: Animals; Cell Line; Chromosome Breakpoints; Chromosomes, Mammalian; Dexrazoxane; DNA; DNA Breaks, Double-Stranded; DNA Repair; DNA Topoisomerases, Type II; Etoposide; Flavonoids; Genistein; Histones; Kaempferols; Luteolin; Mice; Mouse Embryonic Stem Cells; Quercetin; Topoisomerase II Inhibitors; Translocation, Genetic | 2020 |
Transcriptome modulation following administration of luteolin to bleomycin-etoposide-cisplatin chemotherapy on rat LC540 tumor Leydig cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Leydig Cells; Luteolin; Male; Rats; Testicular Neoplasms; Transcriptome | 2021 |